LUCID DIAGNOSTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6831 USD | -5.52% |
|
-14.84% | -51.55% |
| Mar. 27 | Cantor Fitzgerald Trims Price Target on Lucid Diagnostics to $3 From $3.80, Maintains Overweight Rating | MT |
| Mar. 26 | Transcript : Lucid Diagnostics Inc., Q4 2023 Earnings Call, Mar 26, 2024 |
Chart calendar Lucid Diagnostics Inc.
b6ddc421e2310260032d97b2a9.mTtNanp-Aves9Z1Shfq80nzqJwD-3-IB_ZNQBElU-Y0.-mkqMAM6dbH7nNA4656PoAquES2npoxJn6doTRgAo7n0UB0cLw5UnOCdyA~609147ca07e603a64eed5273584c43d5
Upcoming events on Lucid Diagnostics Inc.
Past events on Lucid Diagnostics Inc.
| 2024-04-11 11:00 am | Needham Virtual Healthcare Conference - Fireside Chat |
| 2024-03-26 08:30 am | Business Update Call |
| 2024-03-25 05:30 pm | Q4 2023 Earnings Release |
| 2023-12-13 10:00 am | Investor Day |
| 2023-11-17 | Association for Molecular Pathology Meeting |
| 2023-11-16 10:00 am | Canaccord Genuity MedTech Diagnostics and Digital Health and Services Forum |
| 2023-11-14 08:30 am | Q3 2023 Earnings Call |
| 2023-11-13 05:40 pm | Q3 2023 Earnings Release |
| 2023-08-15 08:30 am | Business Update Call |
| 2023-08-09 11:30 am | Canaccord Genuity Growth Conference |
| 2023-06-21 11:00 am | Annual General Meeting |
| 2023-05-16 08:30 am | Business Update Call |
| 2023-05-15 06:21 pm | Q1 2023 Earnings Release |
| 2023-04-20 11:00 am | Needham Healthcare Conference |
| 2023-03-14 08:30 am | Business Update Call - Fourth Quarter Results |
| 2023-03-13 06:21 pm | Q4 2022 Earnings Release |
| 2022-11-17 11:00 am | Canaccord Genuity CG MedTech, Diagnostics and Digital Health & Services Forum |
| 2022-11-14 04:40 pm | Q3 2022 Earnings Release |
| 2022-11-14 04:30 pm | Q3 2022 Earnings Call |
| 2022-08-15 | Needham Virtual MedTech & Diagnostics Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,50 0,60 -17% | 0,38 0,70 -45.88% | 2,43 2,46 -1.16% | 5,73 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -27,4 -19,7 -39.4% | -54,2 -52,6 -3.11% | -46,0 -48,9 5.87% | -40,9 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -27,4 -20,5 -33.68% | -56,2 -54,7 -2.61% | -48,5 -48,0 -1.03% | -45,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -28,1 -23,1 -21.46% | -56,2 -55,7 -0.85% | -52,7 -53,1 0.76% | -46,7 |
|
Net income Million USD | Released Forecast Spread | -8,28 | -28,1 -22,7 -23.64% | -56,2 -54,8 -2.43% | -52,7 -53,3 1.26% | -47,0 |
|
EPS USD | Released Forecast Spread | -0,59 | -1,51 -1,37 -10.22% | -1,55 -1,54 -0.98% | -1,26 -1,26 0.32% | -1,00 |
| Announcement Date | 22/09/21 | 28/03/22 | 14/03/23 | 25/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,30 0,40 -25.45% | 0,19 0,45 -58.42% | 0,00 0,64 - | 0,08 0,43 -82.12% | 0,11 0,38 -70.51% | 0,45 0,23 94.59% | 0,16 0,61 -74.1% | 0,78 0,79 -1.21% | 1,04 1,06 -1.47% | 1,05 | 1,29 | 1,56 | 1,87 | 1,63 |
|
EBITDA Million USD | Released Forecast Spread | -11,2 -6,07 -85.29% | -12,2 -10,1 -21.25% | -13,9 -10,9 -27.41% | -13,8 -12,2 -12.99% | -14,3 -12,6 -13.6% | -15,7 -10,6 -48.39% | -10,7 -11,5 7.3% | -13,6 -9,50 -42.63% | -10,8 -10,1 -7.43% | -9,93 | -10,4 | -10,3 | -10,3 | -9,87 |
|
EBIT Million USD | Released Forecast Spread | -11,2 -6,49 -73.32% | -12,8 -10,6 -20.42% | -14,6 -12,6 -16.3% | -14,3 -13,4 -7.28% | -14,9 -14,0 -6.46% | -14,3 -13,1 -9.09% | -11,6 -13,2 12.41% | -11,1 -11,1 0.08% | -11,5 -11,1 -3.53% | -11,4 | -11,3 | -11,3 | -11,4 | -11,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -11,3 -7,09 -59.39% | -12,3 -11,1 -10.81% | -14,6 -12,6 -16.37% | -14,3 -14,2 -0.81% | -14,9 -14,4 -3.43% | -16,2 -14,3 -13.35% | -11,4 -13,8 17.33% | -14,2 -11,3 -26.11% | -10,8 -11,2 3.63% | -11,5 | -11,6 | -11,7 | -11,8 | -12,2 |
|
Net income Million USD | Released Forecast Spread | -11,3 -7,13 -58.67% | -12,3 -10,6 -15.49% | -14,6 -12,6 -16.3% | -14,3 -14,4 0.01% | -14,9 -14,0 -6.46% | -16,2 -13,2 -23.23% | -11,4 -13,6 16.59% | -14,2 -11,6 -22.52% | -10,8 -11,5 5.74% | -11,7 | -11,7 | -11,7 | -11,8 | -12,3 |
|
EPS USD | Released Forecast Spread | -0,32 -0,20 -58.02% | -0,35 -0,29 -19.66% | -0,41 -0,36 -13.89% | -0,39 -0,40 1.68% | -0,40 -0,38 -5.26% | -0,40 -0,34 -19.4% | -0,27 -0,32 15.63% | -0,34 -0,27 -24.77% | -0,25 -0,26 3.1% | -0,27 | -0,25 | -0,24 | -0,24 | -0,25 |
| Announcement Date | 28/03/22 | 11/05/22 | 15/08/22 | 14/11/22 | 14/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 25/03/24 | - | - | - | - | - |
More events
Past sector events for Lucid Diagnostics Inc.
| 2024-04-22 06:00 am | GETINGE AB: Q1 2024 Earnings Release |
| 2024-04-19 | SHENZHEN YHLO BIOTECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-03-26 | SHANDONG WEIGAO ORTHOPAEDIC DEVICE CO., LTD: Q4 2023 Earnings Release |
| 2024-03-26 02:00 am | SKAN GROUP AG: Q4 2023 Earnings Release |
| 2024-03-24 | APT MEDICAL INC.: Q4 2023 Earnings Release |
| 2024-02-28 04:05 pm | ZIMVIE INC.: Q4 2023 Earnings Release |
| 2024-02-28 04:05 pm | INARI MEDICAL, INC.: Q4 2023 Earnings Release |
| 2024-02-27 04:05 pm | TREACE MEDICAL CONCEPTS, INC.: Q4 2023 Earnings Release |
| 2024-02-27 04:05 pm | MASIMO CORPORATION: Q4 2023 Earnings Release |
| 2024-02-26 04:09 pm | SI-BONE, INC.: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LUCD Stock
- Calendar Lucid Diagnostics Inc.
